Exagen
XGN
36 hedge funds and large institutions have $47M invested in Exagen in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
6% more funds holding
Funds holding: 34 → 36 (+2)
5.3% more ownership
Funds ownership: 28.55% → 33.85% (+5.3%)
5% more capital invested
Capital invested by funds: $44.7M → $47M (+$2.25M)
58% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$4.47M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.2M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$2.59M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$943K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$282K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$2.38M |
| 2 |
CAC
Cowen and Company
New York
|
-$1.79M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$661K |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$429K |
| 5 |
BlackRock
New York
|
-$141K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $54K | -$10.5K | -817 | -14% |
|
27
New York State Common Retirement Fund
Albany,
New York
| $50K | – | – | – |
|
|
AIG
28
American International Group
New York
| $31K | -$837 | -65 | -2% |
|
29
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $26K | +$2.88K | +224 | +10% |
|
30
Bank of America
Charlotte,
North Carolina
| $22K | -$7.53K | -585 | -22% |
|
31
Legal & General Group
London,
United Kingdom
| $6K | -$3.09K | -240 | -29% |
|
32
Citigroup
New York
| $3K | -$5.34K | -415 | -64% |
|
|
AIP
33
Ameritas Investment Partners
Lincoln,
Nebraska
| $3K | – | – | – |
|
|
PCM
34
Prelude Capital Management
New York
| $1K | -$3.86K | -300 | -72% |
|
|
35
Goldman Sachs
New York
| – | -$2.38M | -191,978 | Closed |
|
36
UBS Group
Zurich,
Switzerland
| – | -$18.9K | -1,466 | -97% |
|
|
CPA
37
Cowen Prime Advisors
New York
| – | -$3K | -500 | Closed |
|
38
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$245 | -19 | -61% |
|
XGN Hedge Fund Activity: Q3 2020 in Review
36 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q3 2020, worth a combined $47M — up 5% from $44.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new XGN positions and 2 closed out — a net gain of 2 holders — while 8 added to existing stakes and 19 trimmed.
The largest buyer was Nomura Holdings, opening a new position worth an estimated $4.47M. The largest seller was Goldman Sachs, exiting entirely with an estimated $2.38M sold.
- 36 institutional investors held Exagen (XGN) as of Q3 2020, up from 34 in Q2 2020.
- Funds reported $47M of Exagen stock for Q3 2020, up 5% quarter-over-quarter.
- 4 funds opened new Exagen positions in Q3 2020 and 2 closed out, a net change of +2 holders.
- The largest Exagen buyer in Q3 2020 was Nomura Holdings, an estimated $4.47M added.
- The largest Exagen seller in Q3 2020 was Goldman Sachs, an estimated $2.38M sold.
Based on aggregated 13F filings for Q3 2020.